Search
Filters
Clear All
  • 3
  • 34

Phase

  • 1
  • 4
  • 1
  • 1
  • 25
  • 36
  • 16

Found 37 COVID trials

A listing of COVID medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab (PROMISE-US)

K
Kassem Bourgi, MD
18 years and older
All genders
Observational
The virological efficacy of ibalizumab has been clearly demonstrated in multiple clinical. This study will expand ibalizumab's clinical data set and allow a better understanding of the virologic response durability on ARV regimens with or without ibalizumabheterogeneous real-world patient population. Additional data on the efficacy and safetybalizumab and its impact …
Learn More

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection (HIKO STEC)

M
Myda Khalid
9-21 years
All genders
Phase 3
Interventional
The objective of this study is to determine if early high volume intravenous fluiddministration (hyperhydration) may be effective in mitigating or preventing complications ofhiga toxin-producing E. coli (STEC) infection in children and adolescents when compared withditional approaches (conservative fluid management).
Learn More

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

S
Scott Goebel, MD
1-30 years
All genders
Phase 2
Interventional
CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) withy cytomegalovirus (CMV) infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ. Funding Source: FDA OOPD
Learn More

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

S
Scott Goebel, MD
1-30 years
All genders
Phase 2
Interventional
Related donor Epstein-Barr Virus (EBV) specific cytotoxic T cells (CTLs) manufactured withhe Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children,dolescents and young adults with refractory EBV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ. Funding Source: FDA OOPD
Learn More

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

S
Scott Goebel, MD
1-30 years
All genders
Phase 1/2
Interventional
BK cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Captureystem will be safe and effective in decreasing specific viral load in children, adolescentsd young adults (CAYA) with refractory BK infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) or with primary immunodeficiencies (PID).
Learn More

Saroglitazar Magnesium 4 mg for NASH in People Living With HIV in the US (SARONAPLUS)

S
Samer Gawrieh, MD
18 years and older
All genders
Phase 2
Interventional
Saroglitazar Magnesium 4 mg for NASH in People Living with HIV in the US
Learn More

Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV

N
Naga Chalasani, MD
18-80 years
All genders
Observational
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions associated withumulation that ranges from benign, non-progressive liver fat accumulation to severever injury, cirrhosis, and liver failure. NAFLD is the most common liver disease in USdults and the second leading cause for liver transplantation in the US. The natural …
Learn More
31 - 37 of 37